Health ❯ Pharmaceuticals ❯ Drug Development

Antimalarial Drugs

Endochin-like Quinolones Coartem Baby GanLum

First New Antimalarial in Decades Tops 97% Cure in Phase III as Novartis Seeks Approval

The ganaplacide–lumefantrine combo could reach patients in roughly 12 to 18 months if regulators grant approval.

Researchers Develop Bed Nets with Antimalarial Compounds to Block Malaria Parasites